Comparative Stroke, Bleeding, and Mortality

ARTICLE IN PRESS Supplementary Figure 1 Age-subgroup-specific adjusted hazard ratios and 95% confidence intervals for thromboem- bolic stroke, intracranial hemorrhage, major extracranial bleeding, and all-cause mortality in elderly patients treated with dabigatran, rivaroxaban, or apixaban compared with warfarin for nonvalvular atrial fibrillation. Graham et al Comparative Safety and Effectiveness of Anticoagulants in Atrial Fibrillation 9.e6